GeneRulor logo

GeneRulor

Empowering precision in molecular diagnostics and gene editing for viral infections and tumor diseases

est. 2019

VS
Nanosphere logo

Nanosphere

41 employees · est. 1999 · Northbrook, United States

Nanosphere is the older company (2019 vs 1999).

Side-by-Side Comparison

GeneRulor Nanosphere
Founded
2019 1999 older
Headquarters
Not tracked yet Northbrook, United States
Employees
Not tracked yet 41
Industry
Biotechnology Biotechnology, Health Care
Funding Stage
Series A Post Ipo Debt
Total Funding
Not tracked yet $125.07M
Funding Rounds
1 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biomedical Company, Molecular Diagnostics, Gene Editing Technology, Viral Infections, Tumor Diseases, Precision Medicine, Genomics, Precision Diagnostics Molecular Diagnostics, Nanotechnology, Clinical Diagnostic Tests, Genetic Variations, Infectious Diseases, Healthcare Economics, Luminex Company, Northbrook, Publicly Traded, Innovation, Microfluidics, Bloodstream Infections, Respiratory Tract Infections, Gastrointestinal Tract Infections
Website
generulor.com nanosphere.us
GeneRulor logo

About GeneRulor

GeneRulor, a biomedical startup founded in 2019, is making significant strides in the biotechnology industry with its cutting-edge molecular diagnostics and gene editing technology. The company's slogan "Empowering precision in molecular diagnostics and gene editing for viral infections and tumor di...

Nanosphere logo

About Nanosphere

Nanosphere is a biotechnology company founded in 1999 and headquartered in Northbrook, Illinois. The company is dedicated to enhancing medicine by providing targeted molecular diagnostic tests for earlier disease detection, optimal patient treatment, and improved healthcare economics. Its platform,...

We will tell you when either one moves

BounceWatch watches GeneRulor and Nanosphere for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at GeneRulor and Nanosphere — by email.

Frequently Asked Questions

GeneRulor — Empowering precision in molecular diagnostics and gene editing for viral infections and tumor diseases. Nanosphere. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
GeneRulor has raised undisclosed funding while Nanosphere has raised $125.07M.
GeneRulor and Nanosphere operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare GeneRulor with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at GeneRulor on 11 Sep 2024, and Nanosphere on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy